- Home
- CRGO vs MOLN Comparison
CRGO vs MOLN Comparison
Compare CRGO & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGO
- MOLN
- Stock Information
- Founded
- CRGO 2012
- MOLN 2004
- Country
- CRGO Spain
- MOLN Switzerland
- Employees
- CRGO N/A
- MOLN N/A
- Industry
- CRGO Blank Checks
- MOLN
- Sector
- CRGO Finance
- MOLN
- Exchange
- CRGO Nasdaq
- MOLN Nasdaq
- Market Cap
- CRGO 134.6M
- MOLN 142.6M
- IPO Year
- CRGO N/A
- MOLN 2021
- Fundamental
- Price
- CRGO $2.89
- MOLN $3.53
- Analyst Decision
- CRGO Buy
- MOLN
- Analyst Count
- CRGO 1
- MOLN 0
- Target Price
- CRGO $3.50
- MOLN N/A
- AVG Volume (30 Days)
- CRGO 97.2K
- MOLN 1.2K
- Earning Date
- CRGO 08-18-2025
- MOLN 08-25-2025
- Dividend Yield
- CRGO N/A
- MOLN N/A
- EPS Growth
- CRGO N/A
- MOLN N/A
- EPS
- CRGO N/A
- MOLN N/A
- Revenue
- CRGO $25,375,000.00
- MOLN $2,525,030.00
- Revenue This Year
- CRGO $26.97
- MOLN N/A
- Revenue Next Year
- CRGO $26.15
- MOLN $1,000.00
- P/E Ratio
- CRGO N/A
- MOLN N/A
- Revenue Growth
- CRGO 21.92
- MOLN N/A
- 52 Week Low
- CRGO $1.27
- MOLN $3.36
- 52 Week High
- CRGO $4.42
- MOLN $9.79
- Technical
- Relative Strength Index (RSI)
- CRGO 60.93
- MOLN 41.49
- Support Level
- CRGO $2.55
- MOLN $3.65
- Resistance Level
- CRGO $3.41
- MOLN $3.96
- Average True Range (ATR)
- CRGO 0.24
- MOLN 0.09
- MACD
- CRGO 0.04
- MOLN -0.01
- Stochastic Oscillator
- CRGO 57.02
- MOLN 20.33
About CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.